SCHEMBL1490469

SCHEMBL1490469

COC(=O)c1c(NC(=O)c2ccc(C)cc2)csc1-c1ccc(C)cc1

nearest known ligand 0.74

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 9/20 0.74
POLB P06746 3/20 0.74
LMNA P02545 3/20 0.74
ALDH1A1 P00352 6/20 0.51
HPGD P15428 4/20 0.51
TP53 P04637 2/20 0.50
KDM4E B2RXH2 4/20 0.49
TSHR P16473 1/20 0.48
MAPK1 P28482 1/20 0.48
HSD17B10 Q99714 1/20 0.48
NPC1 O15118 4/20 0.46
RAB9A P51151 4/20 0.46
MEN1 O00255 2/20 0.46
KMT2A Q03164 2/20 0.46
CYP1A2 P05177 1/20 0.45
CYP2C19 P33261 1/20 0.45
TDP1 Q9NUW8 1/20 0.45
THRB P10828 1/20 0.44
MAPK10 P53779 1/20 0.44
NPSR1 Q6W5P4 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1490816 0.86 MAPT (0.58) MAPTPOLBLMNAALDH1A1HPGD
SCHEMBL1490650 0.83 MAPT (0.52) MAPTPOLBLMNAALDH1A1HPGD
SCHEMBL1490609 0.81 NPC1 (0.64) MAPTPOLBLMNAALDH1A1HPGD
SCHEMBL1490525 0.81 MEN1 (0.64) MAPTPOLBLMNAALDH1A1HPGD
SCHEMBL1490436 0.81 MAPT (0.52) MAPTPOLBLMNAALDH1A1HPGD
SCHEMBL12756874 0.81 NPC1 (0.64) MAPTPOLBLMNAALDH1A1HPGD
SCHEMBL1490465 0.81 MAPT (0.52) MAPTPOLBLMNAALDH1A1HPGD
SCHEMBL12756899 0.78 MAPT (0.51) MAPTPOLBLMNAALDH1A1HPGD
SCHEMBL1490684 0.77 NPC1 (0.52) MAPTPOLBLMNAALDH1A1HPGD
SCHEMBL12831047 0.77 POLB (0.47) MAPTPOLBLMNAALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20140051711-A1 COMPOUNDS THAT MODULATE INTRACELLULAR CALCIUM CALCIMEDICA INC. (US) 2014-02-20 US disclosed
US-20140051711-A1 COMPOUNDS THAT MODULATE INTRACELLULAR CALCIUM CALCIMEDICA INC. (US) 2014-02-20 US disclosed
US-8618307-B2 Compounds that modulate intracellular calcium CALCIMEDICA, INC. (US) 2013-12-31 US disclosed
EP-2477982-A2 COMPOUNDS THAT MODULATE INTRACELLULAR CALCIUM Calcimedica, Inc. (US) 2012-07-25 EP disclosed
WO-2011034962-A2 COMPOUNDS THAT MODULATE INTRACELLULAR CALCIUM CALCIMEDICA INC. (US) 2011-03-24 WO disclosed
WO-2011034962-A2 COMPOUNDS THAT MODULATE INTRACELLULAR CALCIUM CALCIMEDICA INC. (US) 2011-03-24 WO disclosed
US-20110065724-A1 COMPOUNDS THAT MODULATE INTRACELLULAR CALCIUM CALCIMEDICA, INC. (US) 2011-03-17 US disclosed
US-20110065724-A1 COMPOUNDS THAT MODULATE INTRACELLULAR CALCIUM CALCIMEDICA, INC. (US) 2011-03-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140051711-A1 COMPOUNDS THAT MODULATE INTRACELLULAR CALCIUM ORAI1, SARAF, RYR2 MAPT 1478/4885POLB 4774/4885LMNA 1306/4885
US-20110065724-A1 COMPOUNDS THAT MODULATE INTRACELLULAR CALCIUM ORAI1, SARAF, RYR2 MAPT 1478/4885POLB 4774/4885LMNA 1306/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.